Represented large health system in dissolution of large-scale, joint-venture operations with another large health system.
Represented gastroenterology group in $291 million sale of physician practice to national physician management platform.
Represented emergency medicine physician group in $52 million sale of physician practice to national physician management platform.
Represented private equity-backed nephrology platform in creation of the platform and initial acquisition of nephrology practice with enterprise value of $4 million and in subsequent nephrology practice acquisitions valued at $9 million and $11.75 million.
Represented lender in acquisition and combination of two distressed ophthalmology platforms after the platforms began defaulting on their lines of credit.
Represented for-profit health system in the acquisition of multiple ambulatory surgery centers, including managing the licensing and state Medicaid change of ownership filings.
Represented urology group in the sale of their practice to national urology platform in acquisition valued at $32 million.
Represented acquirer of home health and hospice business in connection with the necessary change of ownership filings.
Represented purchaser of physical therapy platform focused on treating workers' compensation and medical lien patients and valued at $47 million that involved a complete restructuring of the platform to bring it into compliance with state fraud and abuse laws.
Regulatory & Advisory
Represented county hospital district in regulatory matters, including submitting hospital license waiver requests to the Texas Health and Human Services Commission, as well as responding to requests submitted under the Texas Public Information Act.
Represented anesthesiology practice in general corporate and regulatory compliance matters regarding the amendment of an affiliated clinically integrated network's governance documents.
Represented for-profit health system in general corporate governance matters, including formation and recertification of nonprofit health organizations.
Represented public company in connection with renewal of pharmacy licenses for various nationwide pharmacy subsidiaries.
Represented laboratory in relation to the marketing of generic biopharmaceutical products in comparison with the related brand-name biopharmaceutical product.
Represented provider network in examining state laws regarding the provision of healthcare services to inmates of state and county correctional facilities.
Represented high-profile individual in the negotiation of a nursing services contract, which involved analysis of various trademark and intellectual property concerns.
Represented individual provider in creation and review of a program to begin accepting payment in the form of medical liens for patients involved in accidents resulting in personal injury legal settlements.
Represented company in transitioning Texas Medicaid contracts as part of a change of ownership and in communications to the Texas Health and Human Services Commission contesting previously adopted provisions of the agency.
Represented health plan in contesting the award of contracts under the STAR/CHIP program.
Represented physician practice in negotiations with data broker regarding the use and licensing of research data generated by the physician practice.
Represented large health system in dissolution of large-scale, joint-venture operations with another large health system. Represented gastroenterology group in $291 million sale of physician practice to national physician management platform. Represented emergency medicine physician group in $52 million sale of physician practice to national physician management platform. Represented private equity-backed nephrology platform in creation of the platform and initial acquisition of nephrology practice with enterprise value of $4 million and in subsequent nephrology practice acquisitions valued at $9 million and $11.75 million. Represented lender in acquisition and combination of two distressed ophthalmology platforms after the platforms began defaulting on their lines of credit. Represented for-profit health system in the acquisition of multiple ambulatory surgery centers, including managing the licensing and state Medicaid change of ownership filings. Represented urology group in the sale of their practice to national urology platform in acquisition valued at $32 million. Represented acquirer of home health and hospice business in connection with the necessary change of ownership filings. Represented purchaser of physical therapy platform focused on treating workers' compensation and medical lien patients and valued at $47 million that involved a complete restructuring of the platform to bring it into compliance with state fraud and abuse laws.
